The muscarinic M1 receptor modulates associative learning and memory in psychotic disorders

被引:6
|
作者
Bakker, Geor [1 ,2 ]
Vingerhoets, Claudia [1 ,2 ]
Bloemen, Oswald J. N. [1 ,3 ]
Sahakian, Barbara J. [4 ]
Booij, Jan [2 ]
Caan, Matthan W. A. [5 ]
van Amelsvoort, Therese A. M. J. [1 ]
机构
[1] Univ Maastricht, Dept Psychiat & Psychol, Maastricht, Netherlands
[2] Univ Amsterdam, Amsterdam Univ, Dept Radiol & Nucl Med, Locat AMC,Med Ctr, Amsterdam, Netherlands
[3] Ctr Mental Hlth Care Innova, GGZ Cent, Amersfoort, Netherlands
[4] Univ Cambridge, Dept Psychiat, Cambridge, Cambs, England
[5] Univ Amsterdam, Amsterdam Univ, Dept Biomed Engn & Phys, Locat AMC,Med Ctr, Amsterdam, Netherlands
关键词
SCHIZOPHRENIA; COGNITION; BRAIN; PERFORMANCE; DYSFUNCTION; ACTIVATION; BIPERIDEN; DEFICITS; AGONIST; BINDING;
D O I
10.1016/j.nicl.2020.102278
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Background: Psychotic disorders are characterized by prominent deficits in associative learning and memory for which there are currently no effective treatments. Functional magnetic resonance imaging (fMRI) studies in psychotic disorders have identified deficits in fronto-temporal activation during associative learning and memory. The underlying pathology of these findings remains unclear. Postmortem data have suggested these deficits may be related to loss of muscarinic M-1 receptor mediated signaling. This is supported by an in-vivo study showing improvements in these symptoms after treatment with the experimental M-1/4 receptor agonist xanomeline. The current study tests whether reported deficits in fronto-temporal activation could be mediated by loss of M-1 receptor signaling in psychotic disorders. Methods: Twenty-six medication-free subjects diagnosed with a psychotic disorder and 29 age-, gender-, and IQ-matched healthy controls underwent two functional magnetic resonance imaging (fMRI) sessions, one under placebo and one under selective M-1 antagonist biperiden, while performing the paired associated learning task. M-1 binding potentials (BPND) were measured in the dorsolateral prefrontal cortex (DLPFC) and hippocampus using I-123-IDEX single photon emission computed tomography. Results: In the subjects with psychotic disorders DLPFC hypoactivation was only found in the memory phase of the task. In both learning and memory phases of the task, M-1 antagonism by biperiden elicited significantly greater hyperactivation of the parahippocampal gyrus and superior temporal gyrus in subjects with a psychotic disorders compared to controls. Greater hyperactivation of these areas after biperiden was associated with greater hippocampal M-1 receptor binding during learning, with no association found with M-1 receptor binding in the DLPFC. M-1 receptor binding in the DLPFC was related to greater functional sensitivity to biperiden of the cingulate gyrus during the memory phase. Conclusion: The current study is the first to show differences in M-1 receptor mediated functional sensitivity between subjects with a psychotic disorder and controls during a paired associate learning and memory task. Results point to subjects with psychotic disorders having a loss of M-1 receptor reserve in temporal-limbic areas.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] MUSCARINIC M1 RECEPTOR SIGNALLING UNDERLYING COGNITION IN PSYCHOTIC DISORDERS
    van Amelsvoort, Therese
    Bakker, Geor
    Vingerhoets, Claudia
    Sahakian, Barbara J.
    Bloemen, Oswald
    Caan, Matthan
    Booij, Jan
    SCHIZOPHRENIA BULLETIN, 2018, 44 : S275 - S276
  • [2] The importance of M1 muscarinic receptor phosphorylation in learning and memory
    McFall, Aisling
    Molloy, Colin
    Lindsley, Craig
    Conn, P. Jeffrey
    Tobin, Andrew
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2022, 42 (1_SUPPL): : 315 - 315
  • [3] The importance of M1 muscarinic receptor phosphorylation in learning and memory
    McFall, Aisling
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (04) : 503 - 503
  • [4] An Antibody Biosensor Establishes the Activation of the M1 Muscarinic Acetylcholine Receptor during Learning and Memory
    Butcher, Adrian J.
    Bradley, Sophie J.
    Prihandoko, Rudi
    Brooke, Simon M.
    Mogg, Adrian
    Bourgognon, Julie-Myrtille
    Macedo-Hatch, Timothy
    Edwards, Jennifer M.
    Bottrill, Andrew R.
    Challiss, R. A. John
    Broad, Lisa M.
    Felder, Christian C.
    Tobin, Andrew B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (17) : 8862 - 8875
  • [5] Autoantibodies against M1 muscarinic acetylcholine receptor in myasthenic disorders
    Takamori, M.
    Motomura, M.
    Fukudome, T.
    Yoshikawa, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (11) : 1230 - 1235
  • [6] Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory
    Fornari, RV
    Moreira, KM
    Oliveira, MGM
    LEARNING & MEMORY, 2000, 7 (05) : 287 - 292
  • [7] Muscarinic M1 receptor expression in schizophrenia
    Scarr, E.
    Cowie, T.
    Gibbons, A.
    Kanellakis, S.
    Dean, B.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S218 - S218
  • [8] The effect of the muscarinic M1 receptor antagonist biperiden on cognition in patients with a psychotic disorder and healthy controls
    Vingerhoets, W. A. M.
    Bakker, G.
    Van Dijk, J.
    Bloemen, O.
    Caan, M.
    Booij, J.
    Van Amelsvoort, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S508 - S509
  • [9] The Effect of the Muscarinic M1 Receptor Antagonist Biperiden on Cognition in Patients with a Psychotic Disorder and Healthy Controls
    Vingerhoets, Wilhelmina
    Bakker, Geor
    Bloemen, Oswald
    Caan, Matthan
    Booij, Jan
    van Amelsvoort, Therese
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 361S - 362S
  • [10] Role of hippocampal M1 and M4 muscarinic receptor subtypes in memory consolidation in the rat
    Ferreira, AR
    Fürstenau, L
    Blanco, C
    Kornisiuk, E
    Sánchez, G
    Daroit, D
    Silva, MCE
    Cervenansky, C
    Jerusalinsky, D
    Quillfeldt, JA
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2003, 74 (02) : 411 - 415